Mannitol Administration in Pediatric TBI with Normal CT and Drowsiness
Do not administer mannitol to a child with traumatic brain injury, a normal CT scan, and only drowsiness as a clinical finding. Mannitol is reserved for clinical signs of brain herniation or documented intracranial hypertension, not for isolated altered consciousness with normal imaging.
Clinical Decision Framework
When Mannitol IS Indicated
Mannitol should be administered only when there are clear signs of threatened intracranial hypertension or brain herniation 1:
- Pupillary abnormalities: Mydriasis, anisocoria, or sluggish/absent pupillary responses
- Declining level of consciousness beyond initial presentation
- Focal neurological deficits (abnormal posturing, lateralizing signs)
- Clinical suspicion of herniation syndrome
- Documented elevated ICP (if monitoring is in place)
The 2018 severe TBI guidelines explicitly state: "Osmotherapy is the treatment of choice in patients with signs of brain herniation (mydriasis, anisocoria) and/or neurological worsening not attributable to a systemic cause" 1.
Why Your Scenario Does NOT Meet Criteria
A child who is merely "drowsy" with a normal CT scan does not have evidence of:
- Mass effect requiring urgent decompression
- Documented intracranial hypertension
- Clinical herniation syndrome
Drowsiness alone represents altered consciousness that could be due to:
- Concussion/diffuse injury (not requiring osmotherapy)
- Sedating medications
- Systemic factors (hypoglycemia, hypoxia, hypotension)
- Post-ictal state
Critical Pitfall to Avoid
Prophylactic administration of hyperosmolar therapy in patients without evidence of intracranial hypertension was not superior to crystalloids and is not recommended 1. The evidence shows no benefit and potential harm from unnecessary osmotherapy.
Proper Management Approach
Immediate Actions for Drowsy Child with Normal CT:
Rule out secondary brain insults first 1:
- Check blood glucose (treat if <3 mmol/L)
- Ensure adequate oxygenation
- Maintain cerebral perfusion pressure (MAP adequate for age)
- Assess for ongoing seizure activity
Close neurological monitoring:
- Serial GCS assessments
- Pupillary examinations every 1-2 hours
- Watch for deterioration
Consider ICP monitoring if:
- GCS ≤8 despite normal CT
- Clinical deterioration occurs
- Inability to assess neurological exam (sedated/paralyzed)
If Clinical Deterioration Occurs
Only then consider mannitol with these specifications 2, 1:
Dosing:
- 0.25-1 g/kg IV over 20-30 minutes
- Larger doses (0.5 g/kg over 15 minutes) for acute intracranial hypertensive crisis
- Pediatric dose: 0.5-1 g/kg 2
Administration requirements:
- Use filter for 25% mannitol 2
- Place urinary catheter 2
- Monitor serum osmolality (hold if ≥320 mOsm/kg) 3, 4
- Monitor electrolytes, particularly sodium 4
Important Caveats
Mannitol-Specific Concerns in Children
CNS toxicity risk: Mannitol may increase cerebral blood flow and worsen intracranial hypertension in children who develop generalized cerebral hyperemia during the first 24-48 hours post-injury 4. This makes the timing and indication even more critical.
Renal complications: Children with normal pre-treatment renal function can still develop reversible oliguric acute kidney injury from mannitol 4. Unnecessary administration increases this risk.
Alternative Consideration
If true intracranial hypertension develops, hypertonic saline (3%) is equally effective as mannitol at equiosmolar doses 1. Recent evidence suggests hypertonic saline may have advantages in cerebral perfusion pressure maintenance 5, though a 2025 pediatric study found no mortality difference between agents 6.
Bottom Line
Drowsiness with normal CT does not justify mannitol administration. Focus on identifying and treating secondary insults, close monitoring for deterioration, and reserving osmotherapy for documented or clinically evident intracranial hypertension with specific herniation signs. The threshold for mannitol is clinical or measured evidence of dangerous ICP elevation, not altered mental status alone.